Edition:
United Kingdom

CytomX Therapeutics Inc (CTMX.OQ)

CTMX.OQ on NASDAQ Stock Exchange Global Select Market

22.49USD
17 Aug 2018
Change (% chg)

$-0.35 (-1.53%)
Prev Close
$22.84
Open
$22.85
Day's High
$22.86
Day's Low
$22.41
Volume
81,521
Avg. Vol
174,336
52-wk High
$34.98
52-wk Low
$13.51

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 21.34 -0.345
Mar '18 14.18 -0.401
FY 2017 Dec '17 27.07 -0.653
Sep '17 24.14 -0.277
Jun '17 8.75 -0.686
Mar '17 11.65 -0.226
FY 2016 Dec '16 6.27 -0.385
Sep '16 3.45 -0.404
Jun '16 3.09 -0.393
Mar '16 2.22 -0.444
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 7 16.16 28.20 8.00 --
Quarter Ending Dec-18 7 20.54 40.30 8.00 --
Year Ending Dec-18 7 72.22 104.00 51.50 60.52
Year Ending Dec-19 7 65.39 104.00 0.00 71.19
Earnings (per share)
Quarter Ending Sep-18 8 -0.39 0.00 -0.67 --
Quarter Ending Dec-18 8 -0.38 0.12 -0.72 --
Year Ending Dec-18 7 -1.52 -0.55 -2.14 -1.50
Year Ending Dec-19 8 -2.33 -0.94 -4.14 -2.50
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.64 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta -- 0.93 0.89
Price to Sales (TTM) 26.31 114.98 5.75
Price to Book (MRQ) 15.16 15.51 5.00
Price to Tangible Book (MRQ) 16.00 14.52 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 76.32 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 182.87 411.54 8.01
Sales (TTM) vs TTM 1 Yr. Ago 225.95 80.50 5.64
Sales - 5 Yr. Growth Rate -- 32.27 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -74.65 29.15 20.60
EPS (TTM) vs TTM 1 Yr. Ago -3.77 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.43 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 5.62 5.53 3.03
LT Debt to Equity (MRQ) 0.00 35.26 12.51
Total Debt to Equity (MRQ) 0.00 37.08 16.85
Interest Coverage (TTM) -- -102.44 32.63

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.17 54.37
Gross Margin - 5 Yr. Avg. -- 50.57 52.17
EBITD Margin (TTM) -203.90 -- --
EBITD - 5 Yr. Avg -- -603.21 10.65
Operating Margin (TTM) -209.53 -759.76 4.32
Operating Margin - 5 Yr. Avg. -- -625.13 6.06
Pre-Tax Margin (TTM) -206.33 -733.60 5.18
Pre-Tax Margin - 5 Yr. Avg. -- -628.46 6.49
Net Profit Margin (TTM) -206.33 -734.98 1.48
Net Profit Margin - 5 Yr. Avg. -- -631.51 2.77
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 386,295 23,229,989 860,375,103
Net Income/Employee (TTM) -797,026 3,144,143 101,207,184
Receivable Turnover (TTM) 103.37 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.11 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -22.25 -0.16 11.13
Return on Assets - 5 Yr. Avg. -- 3.50 12.40
Return on Investment (TTM) -26.13 1.78 14.61
Return on Investment - 5 Yr. Avg. -- 2.55 16.13
Return on Equity (TTM) -81.04 3.28 16.33
Return on Equity - 5 Yr. Avg. -- 3.42 17.39
  1 Year 3 Year 5 Year
Sales % 95.06 156.83 --
EPS (TTM) % 66.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for CytomX Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 25.29 20.97 85 53
13 Week 32.88 26.41 82 66
26 Week 25.44 15.90 73 80
52 Week 39.97 18.64 73 50
YTD 95.63 71.81 85 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 74.19%
# of Holders: 214
Total Shares Held: 33,356,324
3 Mo. Net Change: 2,998,418
# New Positions: 31
# Closed Positions: 27
# Increased Positions: 122
# Reduced Positions: 82
# Net Buyers: 40
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.